Journal article
Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer’s disease subjects
Molecular Neurodegeneration, Vol.7(1), Article number: 16
2012
Abstract
Background
Alcadeinα (Alcα) is a neuronal membrane protein that colocalizes with the Alzheimer's amyloid-β precursor protein (APP). Successive cleavage of APP by β- and γ-secretases generates the aggregatable amyloid-β peptide (Aβ), while cleavage of APP or Alcα by α- and γ-secretases generates non-aggregatable p3 or p3-Alcα peptides. Aβ and p3-Alcα can be recovered from human cerebrospinal fluid (CSF). We have previously reported alternative processing of APP and Alcα in the CSF of some patients with sporadic mild cognitive impairment (MCI) and AD (SAD).
Results
Using the sandwich enzyme-linked immunosorbent assay (ELISA) system that detects total p3-Alcα, we determined levels of total p3-Alcα in CSF from subjects in one of four diagnostic categories (elderly controls, MCI, SAD, or other neurological disease) derived from three independent cohorts. Levels of Aβ40 correlated with levels of total p3-Alcα in all cohorts.
Conclusions
We confirm that Aβ40 is the most abundant Aβ species, and we propose a model in which CSF p3-Alcα can serve as a either (1) a nonaggregatable surrogate marker for γ-secretase activity; (2) as a marker for clearance of transmembrane domain peptides derived from integral protein catabolism; or (3) both. We propose the specification of an MCI/SAD endophenotype characterized by co-elevation of levels of both CSF p3-Alcα and Aβ40, and we propose that subjects in this category might be especially responsive to therapeutics aimed at modulation of γ-secretase function and/or transmembrane domain peptide clearance. These peptides may also be used to monitor the efficacy of therapeutics that target these steps in Aβ metabolis
Details
- Title
- Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer’s disease subjects
- Authors/Creators
- S. Hata (Author/Creator) - Hokkaido UniversityM. Taniguchi (Author/Creator) - Tottori UniversityY. Piao (Author/Creator) - Hokkaido UniversityT. Ikeuchi (Author/Creator) - Niigata UniversityA.M. Fagan (Author/Creator) - Washington University in St. LouisD.M. Holtzman (Author/Creator) - Washington University in St. LouisR. Bateman (Author/Creator) - Washington University in St. LouisH.R. Sohrabi (Author/Creator) - Edith Cowan UniversityR.N. Martins (Author/Creator) - Edith Cowan UniversityS. Gandy (Author/Creator) - James J. Peters VA Medical CenterK. Urakami (Author/Creator) - Tottori UniversityT. Suzuki (Author/Creator) - Hokkaido University
- Publication Details
- Molecular Neurodegeneration, Vol.7(1), Article number: 16
- Publisher
- Biomed Central
- Identifiers
- 991005545415207891
- Copyright
- © 2012 Hata et al.
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Metrics
27 File views/ downloads
17 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.52 Neurodegenerative Diseases
- 1.52.57 Alzheimer's Mechanisms
- Web Of Science research areas
- Neurosciences
- ESI research areas
- Neuroscience & Behavior